1.
Ahmet Emre Eskazan, Teoman Soysal. The tolerability issue of generic imatinib in patients with chronic myeloid leukemia (Comment on Adi J. Klil-Drori et al., Haematologica 2019;104(7):e293). Haematologica 2019;104(7):e330-e330; https://doi.org/10.3324/haematol.2019.222000.